D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 63 Citations 18,627 313 World Ranking 4443 National Ranking 319
Medicine D-index 71 Citations 16,888 411 World Ranking 14460 National Ranking 667

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Surgery

The scientist’s investigation covers issues in Internal medicine, Mutation, Genetics, Immunology and Missense mutation. Johannes Oldenburg has researched Internal medicine in several fields, including Gastroenterology, Endocrinology and Surgery. Johannes Oldenburg regularly ties together related areas like Molecular biology in his Genetics studies.

He usually deals with Immunology and limits it to topics linked to Allele and Single-nucleotide polymorphism. His research on Missense mutation also deals with topics like

  • Genotype that connect with fields like Haemophilia,
  • Virology and Coagulopathy most often made with reference to Haemophilia A. As a part of the same scientific study, Johannes Oldenburg usually deals with the Clotting factor, concentrating on Gamma-glutamyl carboxylase and frequently concerns with Warfarin resistance.

His most cited work include:

  • Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2 (976 citations)
  • Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2 (976 citations)
  • Emicizumab Prophylaxis in Hemophilia A with Inhibitors (387 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Internal medicine, Genetics, Haemophilia, Immunology and Haemophilia A. His Internal medicine research includes elements of Gastroenterology, Endocrinology and Surgery. His studies link Molecular biology with Genetics.

In the field of Haemophilia, his study on Haemophilia B overlaps with subjects such as In patient. Johannes Oldenburg is interested in Antibody, which is a field of Immunology. His Missense mutation study combines topics in areas such as Gene mutation, Compound heterozygosity and Genotype.

He most often published in these fields:

  • Internal medicine (24.57%)
  • Genetics (19.89%)
  • Haemophilia (18.32%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (24.57%)
  • Haemophilia A (16.48%)
  • Haemophilia (18.32%)

In recent papers he was focusing on the following fields of study:

Johannes Oldenburg mainly investigates Internal medicine, Haemophilia A, Haemophilia, Pediatrics and Emicizumab. His Internal medicine study frequently draws connections between related disciplines such as Gastroenterology. The Haemophilia A study combines topics in areas such as Observational study, Quality of life and Intensive care medicine.

His Haemophilia study combines topics from a wide range of disciplines, such as Young adult, Regimen and Thrombotic microangiopathy. His Pediatrics research is multidisciplinary, relying on both Health related quality of life and MEDLINE. The study incorporates disciplines such as Mutation, Missense mutation and Cohort in addition to Von Willebrand disease.

Between 2017 and 2021, his most popular works were:

  • Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors (201 citations)
  • A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors. (64 citations)
  • Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis. (35 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Surgery

Internal medicine, Haemophilia, Pediatrics, In patient and Haemophilia A are his primary areas of study. Johannes Oldenburg combines subjects such as Gastroenterology and Genotype with his study of Internal medicine. Within one scientific family, he focuses on topics pertaining to Young adult under Haemophilia, and may sometimes address concerns connected to Severity of illness.

As part of the same scientific family, Johannes Oldenburg usually focuses on Haemophilia A, concentrating on Quality of life and intersecting with Dosing, Factor IX and Haemophilia B. His Endogeny study also includes

  • Von Willebrand factor, which have a strong connection to Missense mutation, Molecular pathology, Mutation and Allele,
  • Immunology, which have a strong connection to Transcriptome. To a larger extent, Johannes Oldenburg studies Genetics with the aim of understanding Gene.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

Simone Rost;Andreas Fregin;Vytautas Ivaskevicius;Ernst Conzelmann.
Nature (2004)

1346 Citations

Emicizumab Prophylaxis in Hemophilia A with Inhibitors

Johannes Oldenburg;Johnny N. Mahlangu;Benjamin Kim;Christophe Schmitt.
The New England Journal of Medicine (2017)

519 Citations

The Genetic Basis of Resistance to Anticoagulants in Rodents

Hans-Joachim Pelz;Simone Rost;Mirja Hünerberg;Andreas Fregin.
Genetics (2005)

355 Citations

Haemophilia A: mutation type determines risk of inhibitor formation.

Rainer Schwaab;H.-H. Brackmann;C. Meyer;J. Seehafer.
Thrombosis and Haemostasis (1995)

353 Citations

VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation

Christof Geisen;Matthias Watzka;Katja Sittinger;Michael Steffens.
Thrombosis and Haemostasis (2005)

342 Citations

F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis

Samantha C. Gouw;Samantha C. Gouw;H. Marijke van den Berg;Johannes Oldenburg;Jan Astermark.
Blood (2012)

334 Citations

Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A.

Jan Astermark;Johannes Oldenburg;Anna Pavlova;Erik Berntorp.
Blood (2006)

321 Citations

Immune Tolerance for the Treatment of Factor VIII Inhibitors ‐ Twenty Years' ‘Bonn Protocol’

H. H. Brackmann;J. Oldenburg;R. Schwaab.
Vox Sanguinis (1996)

305 Citations

Genetic risk factors for inhibitors to factors VIII and IX.

J. Oldenburg;A. Pavlova.
Haemophilia (2006)

297 Citations

Gender specific differences in levels of DNA methylation at selected loci from human total blood: a tendency toward higher methylation levels in males.

Osman El-Maarri;Tim Becker;Judith Junen;Syed Saadi Manzoor.
Human Genetics (2007)

287 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Johannes Oldenburg

Flora Peyvandi

Flora Peyvandi

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Publications: 91

Erik Berntorp

Erik Berntorp

Lund University

Publications: 63

Pier Mannuccio Mannucci

Pier Mannuccio Mannucci

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Publications: 53

Sébastien Lacroix-Desmazes

Sébastien Lacroix-Desmazes

Université Paris Cité

Publications: 51

Kathelijn Fischer

Kathelijn Fischer

Utrecht University

Publications: 49

Darrel W. Stafford

Darrel W. Stafford

University of North Carolina at Chapel Hill

Publications: 43

Massimo Franchini

Massimo Franchini

University of Verona

Publications: 43

Ulrich Spengler

Ulrich Spengler

University of Bonn

Publications: 33

Peter Collins

Peter Collins

Cardiff University

Publications: 31

Ingrid Pabinger

Ingrid Pabinger

Medical University of Vienna

Publications: 30

Jürgen K. Rockstroh

Jürgen K. Rockstroh

University Hospital Bonn

Publications: 27

Valder R. Arruda

Valder R. Arruda

University of Pennsylvania

Publications: 26

Jan Voorberg

Jan Voorberg

University of Amsterdam

Publications: 26

Marilyn J. Manco-Johnson

Marilyn J. Manco-Johnson

University of Colorado Anschutz Medical Campus

Publications: 24

Giuseppe Lippi

Giuseppe Lippi

University of Verona

Publications: 23

Emmanuel J. Favaloro

Emmanuel J. Favaloro

Westmead Hospital

Publications: 22

Trending Scientists

Sandeep K. S. Gupta

Sandeep K. S. Gupta

Arizona State University

Bharat L. Bhuva

Bharat L. Bhuva

Vanderbilt University

M.Y. He

M.Y. He

University of California, Santa Barbara

Tao Wang

Tao Wang

Peking University

David N. Seidman

David N. Seidman

Northwestern University

Paul R. Jensen

Paul R. Jensen

University of California, San Diego

Kousaku Murata

Kousaku Murata

Setsunan University

Manfred Schmidt

Manfred Schmidt

German Cancer Research Center

Mark A. Moline

Mark A. Moline

University of Delaware

David J. Nowak

David J. Nowak

US Forest Service

Francesco Lacquaniti

Francesco Lacquaniti

University of Rome Tor Vergata

Elliot Aronson

Elliot Aronson

University of California, Santa Cruz

Milton E. Strauss

Milton E. Strauss

Case Western Reserve University

Peter Woods

Peter Woods

The Open University

Jill Blackmore

Jill Blackmore

Deakin University

Sahar S. Allam

Sahar S. Allam

Fermilab

Something went wrong. Please try again later.